发明名称 Treatment of disorders secondary to organic impairments
摘要 A method for treatment of neuropsychiatric symptoms or disorders emanating from primary brain or systemic impairments includes administration of an effective dose of a dopamine, serotonin, and norepinephrine reuptake inhibitor to a human in need of such treatment. The preferred reuptake inhibitor is sibutramine.
申请公布号 US6323242(B1) 申请公布日期 2001.11.27
申请号 US19980204124 申请日期 1998.12.02
申请人 MUELLER PETER STERLING 发明人 MUELLER PETER STERLING
分类号 A61K45/00;A61K31/00;A61K31/135;A61K31/137;A61P3/00;A61P5/00;A61P15/00;A61P25/00;A61P25/08;A61P25/14;A61P25/18;A61P25/20;A61P25/30;A61P25/36;A61P27/02;A61P31/12;(IPC1-7):A61K31/36;C07C211/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址